TEL/AML1 shows dominant-negative effects over TEL as well as AML1

Biochemical and Biophysical Research Communications

Volumn 322, Issue 2, 2004, Pages 623-630

  Gunji, Hisako ^a   Waga, Kazuo ^a   Nakamura, Fumihiko ^a   Maki, Kazuhiro ^a   Sasaki, Ko ^a   Nakamura, Yuichi ^b   Mitani, Kinuko ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

AML1; Dominant negative effects; ETS; HLH; Leukemia; t(12; 21); TEL; TEL AML1; Transcription factor; Tumor suppressor

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; ONCOPROTEIN; REPRESSOR PROTEIN; RUNX1 PROTEIN, MOUSE; TEL AML1 FUSION PROTEIN; TEL-AML1 FUSION PROTEIN; TRANSCRIPTION FACTOR ETS;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL LINE; CONTROLLED STUDY; GENE EXPRESSION; GROWTH INHIBITION; LEUKEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; WILD TYPE; ANIMAL; B CELL LEUKEMIA; CELL STRAIN 3T3; CELL STRAIN COS1; CERCOPITHECUS; GENE EXPRESSION REGULATION; GENE TRANSLOCATION; GENETIC EPISTASIS; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; CERCOPITHECUS AETHIOPS; CORE BINDING FACTOR ALPHA 2 SUBUNIT; COS CELLS; DNA-BINDING PROTEINS; EPISTASIS, GENETIC; GENE EXPRESSION REGULATION; LEUKEMIA, B-CELL; MICE; NIH 3T3 CELLS; ONCOGENE PROTEINS, FUSION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 6044226989     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.07.169     Document Type: Article

References (52)

1. T.R. Golub, G.F. Barker, M. Lovett, and D.G. Gilliland Fusion of PDGF receptor b to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation Cell 77 1994 307 316
2. H. Poirel, C. Oury, C. Carron, E. Duprez, Y. Laabi, A. Tsapis, S.P. Romana, M. Mauchauffe, M. Le Coniat, R. Berger, J. Ghysdael, and O.A. Bernard The TEL gene products: nuclear phosphoproteins with DNA binding properties Oncogene 14 1997 349 357
3. R.G. Lopez, C. Carron, C. Oury, P. Gardellin, O. Bernard, and J. Ghysdael TEL is a sequence-specific transcriptional repressor J. Biol. Chem. 274 1999 30132 30138
4. L.V. Rompaey, M. Potter, C. Adams, and G. Grosveld Tel induces a G1 arrest and suppresses Ras-induced transformation Oncogene 19 2000 5244 5250
5. R. Fenrick, L. Wang, J. Nip, J.M. Amann, R.J. Rooney, J. Walker-Daniels, H.C. Crawford, D.L. Hulboy, M.S. Kinch, L.M. Matrisian, and S.W. Hiebert TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras- transformed cells while repressing the transcription of stromelysin-1 Mol. Cell. Biol. 20 2000 5828 5839
6. C.A. Kim, M.L. Phillips, W. Kim, M. Gingery, H.H. Tran, M.A. Robinson, S. Faham, and J.U. Bowie Polymerization of the SAM domain of TEL in leukemogenesis and transcriptional repression EMBO J. 20 2001 4173 4182
7. B.A. Kwiatkowski, L.S. Bastian, T.R. Bauer Jr., S. Tsai, A.G. Zielinska- Kwiatkowska, and D.D. Hickstein The ets family member Tel binds to the Fli-1 oncoprotein and inhibits its transcriptional activity J. Biol. Chem. 273 1998 17525 17530
8. M.D. Potter, A. Buijs, B. Kreider, L. van Rompaey, and G.C. Grosveld Identification and characterization of a new human ETS-family transcription factor, TEL2, that is expressed in hematopoietic tissues and can associate with TEL1/ETV6 Blood 95 2000 3341 3348
9. X. Gu, B.H. Shin, Y. Akbarali, A. Weiss, J. Boltax, P. Oettgen, and T.A. Libermann Tel-2 is a novel transcriptional repressor related to the Ets factor Tel/ETV-6 J. Biol. Chem. 276 2001 9421 9436
10. L. Wang, and S.W. Hiebert TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3 Oncogene 20 2001 3716 3725
11. R. Martinez, and T.R. Golub Transcriptional repression of ID1 by the leukemogenic ETS protein TEL Blood 96 2000 453a
12. L.C. Wang, F. Kuo, Y. Fujiwara, D.G. Gilliland, T.R. Golub, and S.H. Orkin Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL EMBO J. 16 1997 4374 4383
13. L.C. Wang, W. Swat, Y. Fujiwara, L. Davidson, J. Visvader, F. Kuo, F.W. Alt, D.G. Gilliland, T.R. Golub, and S.H. Orkin The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow Genes Dev. 12 1998 2392 2402
14. K. Waga, Y. Nakamura, K. Maki, H. Arai, T. Yamagata, K. Sasaki, M. Kurokawa, H. Hirai, and K. Mitani Leukemia-related transcription factor TEL accelerates differentiation of Friend erythroleukemia cells Oncogene 22 2003 59 68
15. H. Miyoshi, K. Shimizu, T. Kozu, N. Maseki, Y. Kaneko, and M. Ohki t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1 Proc. Natl. Acad. Sci. USA 88 1991 10431 10434
16. H. Miyoshi, T. Kozu, K. Shimizu, K. Enomoto, N. Maseki, Y. Kaneko, N. Kamada, and M. Ohki The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript EMBO J. 12 1993 2715 2721
17. H. Uchida, J. Zhang, and S.D. Nimer AML1A and AML1B can transactivate the human IL-3 promoter J. Immunol. 158 1997 2251 2258
18. A. Takahashi, M. Satake, Y. Yamaguchi-Iwai, S.C. Bae, J. Lu, M. Maruyama, Y.W. Zhang, H. Oka, N. Arai, and K. Arai Positive and negative regulation of granulocyte-macrophage colony-stimulating factor promoter activity by AML1-related transcription factor, PEBP2 Blood 86 1995 607 616
19. D.E. Zhang, K. Fujioka, C.J. Hetherington, L.H. Shapiro, H.M. Chen, A.T. Look, and D.G. Tenen Identification of a region which directs the monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1) Mol. Cell. Biol. 14 1994 8085 8095
20. B. Lutterbach, J.J. Westendorf, B. Linggi, S. Isaac, E. Seto, and S.W. Hiebert A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia J. Biol. Chem. 275 2000 651 656
21. S. Meyers, J.R. Downing, and S.W. Hiebert Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions Mol. Cell. Biol. 13 1993 6336 6345
22. S. Wang, Q. Wang, B.E. Crute, I.N. Melnikova, S.R. Keller, and N.A. Speck Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor Mol. Cell. Biol. 13 1993 3324 3339
23. E. Ogawa, M. Inuzuka, M. Maruyama, M. Satake, M.N. Fujimoto, Y. Ito, and K. Shigesada Molecular cloning and characterization of PEBP2β, the heterodimeric partner of a novel Drosophila runt-related DNA-binding protein PEBP2a Virology 194 1993 314 331
24. T. Kanno, Y. Kanno, L.F. Chen, E. Ogawa, W.Y. Kim, and Y. Ito Intrinsic transcriptional activation-inhibition domains of the polyomavirus enhancer binding protein 2/core binding factor alpha subunit revealed in the presence of the beta subunit Mol. Cell. Biol. 18 1998 2444 2454
25. I. Kitabayashi, A. Yokoyama, K. Shimizu, and M. Ohki Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation EMBO J. 17 1998 2994 3004
26. I. Nuchprayoon, S. Meyers, L.M. Scott, J. Suzow, S. Hiebert, and A.D. Friedman PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2β/CBFβ proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells Mol. Cell. Biol. 14 1994 5558 5568
27. J.J. Westendorf, C.M. Yamamoto, N. Lenny, J.R. Downing, M.E. Selsted, and S.W. Hiebert The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-α, inhibits C/EBP-α-dependent transcription, and blocks granulocytic differentiation Mol. Cell. Biol. 18 1998 322 333
28. M.T. Corsetti, and F. Calabi Lineage- and stage-specific expression of runt box polypeptides in primitive and definitive hematopoiesis Blood 89 1997 2359 2368
29. T. Okuda, J. van Deursen, S.W. Hiebert, G. Grosveld, and J.R. Downing AML1,the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis Cell 84 1996 321 330
30. M. Niki, H. Okada, H. Takano, J. Kuno, K. Tani, H. Hibino, S. Asano, Y. Ito, M. Satake, and T. Noda Hematopoiesis in the fetal liver is impaired by targeted mutagenesis of a gene encoding a non-DNA binding subunit of the transcription factor, polyomavirus enhancer binding protein 2/core binding factor Proc. Natl. Acad. Sci. USA 94 1997 5697 5702
31. K. Sasaki, H. Yagi, R.T. Bronson, K. Tominaga, T. Matsunashi, K. Deguchi, Y. Tani, T. Kishimoto, and T. Komori Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor β Proc. Natl. Acad. Sci. USA 93 1996 12359 12363
32. T. Tanaka, K. Tanaka, S. Ogawa, M. Kurokawa, K. Mitani, J. Nishida, Y. Shibata, Y. Yazaki, and H. Hirai An acute myeloid leukemia gene, AML1, regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative spliced forms EMBO J. 14 1995 341 350
33. K. Hayashi, N. Abe, T. Watanabe, M. Obinata, M. Ito, T. Sato, S. Habu, and M. Satake Overexpression of AML1 transcription factor drives thymocytes into the CD8 single-positive lineage J. Immunol. 167 2001 4957 4965
34. I. Taniuchi, M. Osato, T. Egawa, M.J. Sunshine, S.C. Bae, T. Komori, Y. Ito, and D.R. Littman Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development Cell 111 2002 621 623
35. E. Woolf, C. Xiao, O. Fainaru, J. Lotem, D. Rosen, V. Negreanu, Y. Bernstein, D. Goldenberg, O. Brenner, G. Berke, D. Levanon, and Y. Groner Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis Proc. Natl. Acad. Sci. USA 100 2003 7731 7736
36. T.W. McLean, S. Ringold, D. Neuberg, K. Stegmaier, R. Tantravahi, J. Ritz, H.P. Koeffler, S. Takeuchi, J.W. Janssen, T. Seriu, C.R. Bartram, S.E. Sallan, D.G. Gilliland, and T.R. Golub TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia Blood 88 1996 4252 4258
37. J.E. Rubnitz, F.G. Behm, D. Wichlan, C. Ryan, J.T. Sandlund, R.C. Ribeiro, G.K. Rivera, M.L. Hancock, M.V. Relling, W.E. Evans, C.H. Pui, and J.R. Downing Low frequency of TEL-AML1 in relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroup Leukemia 13 1999 19 21
38. J.E. Rubnitz, C.H. Pui, and J.R. Downing The role of TEL fusion genes in pediatric leukemias Leukemia 13 1999 6 13
39. T.R. Golub, G.F. Barker, S.K. Bohlander, S.W. Hiebert, D.C. Ward, P. Bray-Ward, E. Morgan, S.C. Raimondi, J.D. Rowley, and D.G. Gilliland Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia Proc. Natl. Acad. Sci. USA 92 1995 4917 4921
40. S.P. Romana, M. Mauchauffe, M. Le Coniat, I. Chumakov, D. Le Paslier, R. Berger, and O.A. Bernard The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion Blood 85 1995 3662 3670
41. S.W. Hiebert, W. Sun, J.N. Davis, T. Golub, S. Shurtleff, A. Buijs, J.R. Downing, G. Grosveld, M.F. Roussell, D.G. Gilliland, N. Lenny, and S. Meyers The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription Mol. Cell. Biol. 16 1996 1349 1355
42. S. Fears, M. Gavin, D.E. Zhang, C. Hetherington, Y. Ben-David, J.D. Rowley, and G. Nucifora Functional characterization of ETV6 and ETV6/CBFA2 in the regulation of the MCSFR proximal promoter Proc. Natl. Acad. Sci. USA 94 1997 1949 1954
43. R. Fenrick, J.M. Amann, B. Lutterbach, L. Wang, J.J. Westendorf, J.R. Downing, and S.W. Hiebert Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein Mol. Cell. Biol. 19 1999 6566 6574
44. F. Guidez, K. Petrie, A.M. Ford, H. Lu, C.A. Bennett, A. MacGregor, J. Hannemann, Y. Ito, J. Ghysdael, M. Greaves, L.M. Wiedemann, and A. Zelent Recruitment of the nuclear receptor corepressor N-CoR by the TEL moiety of the childhood leukemia-associated TEL-AML1 oncoprotein Blood 96 2000 2557 2561
45. H. Arai, K. Maki, K. Waga, K. Sasaki, Y. Nakamura, Y. Imai, M. Kurokawa, H. Hirai, and K. Mitani Functional regulation of TEL by p38-induced phosphorylation Biochem. Biophys. Res. Commun. 299 2002 116 125
46. S.E. McDonnell, L.D. Kerr, and L.M. Matrisian Epidermal growth factor stimulation of stromelysin mRNA in rat fibroblasts requires induction of proto-oncogenes c-fos and c-jun and activation of protein kinase C Mol. Cell. Biol. 10 1990 4284 4293
47. M. Kurokawa, T. Tanaka, K. Tanaka, S. Ogawa, K. Mitani, Y. Yazaki, and H. Hirai Overexpression of the AML1 proto-oncoprotein in NIH3T3 cells leads to neoplastic transformation depending on the DNA-binding and transactivational potencies Oncogene 12 1996 883 892
48. P. Andreasson, J. Schwaller, E. Anastasiadou, J. Aster, and D.G. Gilliland The expression of ETV6/CBFA2 (TEL/AML1) is not sufficient for the transformation of hematopoietic cell lines in vitro or the induction of hematologic disease in vivo Cancer. Genet. Cytogenet. 130 2001 93 104
49. F. Bernardin, Y. Yang, R. Cleaves, M. Zahurak, L. Cheng, C.I. Civin, and A.D. Friedman TEL-AML1, expressed from t(12;21) in human acute lymphocytic leukemia, induces acute leukemia in mice Cancer Res. 62 2002 3904 3908
50. S. Raynaud, H. Cave, M. Baens, C. Bastard, V. Cacheux, J. Grosgeorge, C. Guidal-Giroux, C. Guo, E. Vilmer, P. Marynen, and B. Grandchamp The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia Blood 87 1996 2891 2899
51. D.H. Kim, R.L. Moldwin, C. Vignon, S.K. Bohlander, Y. Suto, L. Giordano, R. Gupta, S. Fears, G. Nucifora, and J.D. Rowley TEL-AML1 translocations with TEL and CDKN2 inactivation in acute lymphoblastic leukemia cell lines Blood 88 1996 785 794
52. K. Maki, H. Arai, K. Waga, K. Sasaki, F. Nakamura, Y. Imai, M. Kurokawa, H. Hirai, and K. Mitani Leukemia-related transcription factor TEL is negatively regulated through ERK-induced phosphorylation Mol. Cell. Biol. 24 2004 3227 3237